Publication | Open Access

A multi-center, single-arm, phase Ib study of pembrolizumab (MK-3475) in combination with chemotherapy for patients with advanced colorectal cancer: HCRN GI14-186

Phase Ib StudyOncologyMedicineColorectal CancerPathologyImmune Checkpoint InhibitorHcrn Gi14-186Cancer TreatmentAdvanced Colorectal CancerPharmacologyRadiation Oncology